What if you invested $1000 in HIMS on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 7 years, Hims & Hers Health Inc. has delivered an average annual return of 29.4%. The stock peaked in 2024 with a massive +150.8% gain, while investors faced a downturn in 2021 (-58.2%). Overall, the stock finished in the green 5 times out of 7 years.
Avg Return
+29.4%
Win Rate
71%
5W - 2L
Best
+150.8%
2024
Worst
-58.2%
2021
Performance Consistency
About Hims & Hers Health Inc.
Visit Website ↗Hims & Hers Health Inc. is a multi-specialty telehealth platform that provides access to personalized health and wellness solutions. The company offers a wide range of products and services, including prescriptions, over-the-counter medications, and supplements, across various categories such as sexual health, hair loss, dermatology, and mental health. Hims & Hers aims to make healthcare more accessible, affordable, and convenient through its digital platform.
Key Business Segments
Hims
Focuses on men's health and wellness, offering solutions for hair loss, sexual health, and mental health.
Hers
Focuses on women's health and wellness, providing solutions for skin care, hair care, sexual health, and mental health.
Key Innovations
- ✓Pioneered a direct-to-consumer telehealth model, offering personalized care and prescription medications for sensitive health conditions.
- ✓Leverages digital platforms to provide convenient access to licensed healthcare professionals and a wide range of health and wellness products.
Historical Milestones
Hims is launched by Andrew Dudum, Jack Abraham, and Joe Spector.
Hers is launched, expanding the platform's offerings to women's health and wellness.
Hims & Hers Health Inc. goes public on the New York Stock Exchange through a SPAC merger.